Transient Myeloproliferative Disorder: An Update for Neonatal Nurses

Area of Science:

• Neonatal Medicine
• Genetics
• Hematology

Background:

• Down syndrome (DS) is a common genetic disorder affecting 1 in 700-1,000 infants.
• Transient myeloproliferative disorder (TMD) is a frequent comorbidity in infants with DS.
• TMD presents with leukocytosis and elevated blast counts, often requiring NICU admission.

Purpose of the Study:

• To highlight the key features of TMD in infants with Down syndrome.
• To emphasize the importance of recognizing TMD's association with acute myeloid leukemia (AML).
• To underscore the role of neonatal nurses in managing and educating families about TMD.

Main Methods:

• Review of existing literature on Down syndrome and transient myeloproliferative disorder.
• Analysis of clinical manifestations and outcomes of TMD in DS infants.
• Discussion of the implications for neonatal nursing care and family support.

Main Results:

• Approximately 10% of infants with DS develop TMD, typically within the first week of life.
• TMD manifestations include jaundice, conjugated hyperbilirubinemia, hepatomegaly, and effusions.
• While TMD generally resolves spontaneously within three months, survivors face an elevated risk of AML.

Conclusions:

• Neonatal nurses require specialized knowledge of TMD to effectively screen DS infants.
• Early identification and management of TMD are crucial for optimizing outcomes.
• Informed family education and coordinated care are essential for infants with DS and TMD.